In gastric cancer, inhibiting CDO1 expression led to the restoration of glutathione levels, increased expression of GPX4, prevented ROS production, and reduced the production of malondialdehyde, which is a final product of lipid peroxidation.69 The gene discussed is CDO1; the disease is gastric cancer.